Paolo Vigneri

16PUBLICATIONS
96CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityMedical infection agents (incl. prions)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 24, 2026
Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study.

|Apr 27, 2026
Preclinical Rationale, Clinical Efficacy, and Safety of the Selective AKT Kinase Inhibitor Capivasertib in Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Carcinoma: A Practical Narrative Review.

|Sep 13, 2025
Unlocking the Potential of Immune Checkpoint Inhibitors in HR+/HER2- Breast Cancer: A Systematic Review.

Giuseppe Di Grazia, Arianna Dri, Angela Grieco

|Jul 28, 2025
Correlation between histopathological features and recurrence score according to menopausal status in HR+/HER2- breast cancer patients: a retrospective study.

Federica Martorana, Sabrina Nucera, Gianmarco Motta

|Jun 27, 2023
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports.

Maria Stella Pennisi, Sandra Di Gregorio, Elena Tirrò

|Apr 28, 2023
Letter to the Editor: statistics and clinical perception of patients' reported outcomes for palbociclib and abemaciclib: a sliding doors story.

Vittorio Gebbia, Maria Rosaria Valerio, Federica Martorana

Pageof 3

Frequent Collaborators

6 joint publications

Elena Tirrò

6 joint publications

Federica Martorana

4 joint publications

Giuseppe Broggi

3 joint publications

Lorenzo Colarossi